1. Lee AC, Kozuki N, Blencowe H, Vos T, Bahalim A, Darmstadt GL, et al. Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990. Pediatr Res. 2013; 74(Suppl 1):50–72. PMID:
24366463.
Article
2. Itoo BA, Al-Hawsawi ZM, Khan AH. Hypoxic ischemic encephalopathy, Incidence and risk factors in North Western Saudi Arabia. Neurosciences (Riyadh). 2003; 8:113–119. PMID:
23649029.
3. Dixon BJ, Reis C, Ho WM, Tang J, Zhang JH. Neuroprotective strategies after neonatal hypoxic ischemic encephalopathy. Int J Mol Sci. 2015; 16:22368–22401. PMID:
26389893.
4. El Shimi MS, Awad HA, Hassanein SM, Gad GI, Imam SS, Shaaban HA, et al. Single dose recombinant erythropoietin versus moderate hypothermia for neonatal hypoxic ischemic encephalopathy in low resource settings. J Matern Fetal Neonatal Med. 2014; 27:1295–1300. PMID:
24134405.
Article
5. Serpero LD, Bellissima V, Colivicchi M, Sabatini M, Frigiola A, Ricotti A, et al. Next generation biomarkers for brain injury. J Matern Fetal Neonatal Med. 2013; 26(Suppl 2):44–49.
Article
6. Hassanein SM, Deifalla SM, El-Houssinie M, Mokbel SA. Safety and efficacy of cerebrolysin in infants with communication defects due to severe perinatal brain insult: a randomized controlled clinical trial. J Clin Neurol. 2016; 12:79–84. PMID:
26365023.
Article
7. Chalak LF, DuPont TL, Sánchez PJ, Lucke A, Heyne RJ, Morriss MC, et al. Neurodevelopmental outcomes after hypothermia therapy in the era of Bayley-III. J Perinatol. 2014; 34:629–633. PMID:
24743133.
Article
8. Horn AR, Swingler GH, Myer L, Linley LL, Raban MS, Joolay Y, et al. Early clinical signs in neonates with hypoxic ischemic encephalopathy predict an abnormal amplitude-integrated electroencephalogram at age 6 hours. BMC Pediatr. 2013; 13:52. PMID:
23574923.
Article
9. Hayakawa M, Ito Y, Saito S, Mitsuda N, Hosono S, Yoda H, et al. Incidence and prediction of outcome in hypoxic-ischemic encephalopathy in Japan. Pediatr Int. 2014; 56:215–221. PMID:
24127879.
10. Menticoglou SM. How often do perinatal events at full term cause cerebral palsy? J Obstet Gynaecol Can. 2008; 30:396–403. PMID:
18505663.
Article
11. Bhongir AV, Yakama AV, Saha S, Radia SB, Pabbati J. The urinary uric acid/creatinine ratio is an adjuvant marker for perinatal asphyxia. Eur J Pharm Med Res. 2015; 2:520–528. PMID:
26998526.
12. Goel M, Dwivedi R, Gohiya P, Hegde D. Nucleated red blood cell in cord blood as a marker of perinatal asphyxia. J Clin Neonatol. 2013; 2:179–182. PMID:
24404530.
Article
13. Aly H, Hassanein S, Nada A, Mohamed MH, Atef SH, Atiea W. Vascular endothelial growth factor in neonates with perinatal asphyxia. Brain Dev. 2009; 31:600–604. PMID:
18926648.
Article
14. Reali C, Scintu F, Pillai R, Cabras S, Argiolu F, Ristaldi MS, et al. Differentiation of human adult CD34
+ stem cells into cells with a neural phenotype: role of astrocytes. Exp Neurol. 2006; 197:399–406. PMID:
16298364.
15. Hobel CJ, Youkeles L, Forsythe A. Prenatal and intrapartum high-risk screening. II. Risk factors reassessed. Am J Obstet Gynecol. 1979; 135:1051–1056. PMID:
517589.
16. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol. 1976; 33:696–705. PMID:
987769.
17. Thompson CM, Puterman AS, Linley LL, Hann FM, van der Elst CW, Molteno CD, et al. The value of a scoring system for hypoxic ischaemic encephalopathy in predicting neurodevelopmental outcome. Acta Paediatr. 1997; 86:757–761. PMID:
9240886.
Article
18. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005; 353:1574–1584. PMID:
16221780.
Article
19. Denning-Kendall PA, Horsley H, Donaldson C, Bradley B, Hows JM. Different behaviour of fresh and cultured CD34
+ cells during immunomagnetic separation. Br J Haematol. 1999; 105:780–785. PMID:
10354147.
20. van Laerhoven H, de Haan TR, Offringa M, Post B, van der Lee JH. Prognostic tests in term neonates with hypoxic-ischemic encephalopathy: a systematic review. Pediatrics. 2013; 131:88–98. PMID:
23248219.
Article
21. Surbek DV, Aufderhaar U, Holzgreve W. Umbilical cord blood collection for transplantation: which technique should be preferred? Am J Obstet Gynecol. 2000; 183:1587–1588. PMID:
11120533.
Article
22. Axt R, Ertan K, Hendrik J, Wrobel M, Mink D, Schmidt W. Nucleated red blood cells in cord blood of singleton term and post-term neonates. J Perinat Med. 1999; 27:376–381. PMID:
10642958.
Article
23. Mehrishi JN, Bakács T. A novel method of CD34
+ cell separation from umbilical cord blood. Transfusion. 2013; 53:2675–2680. PMID:
23432618.
24. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996; 5:213–226. PMID:
8817388.
25. Sidney LE, Branch MJ, Dunphy SE, Dua HS, Hopkinson A. Concise review: evidence for CD34 as a common marker for diverse progenitors. Stem Cells. 2014; 32:1380–1389. PMID:
24497003.
Article
26. Al-Deghaither SY. Impact of maternal and neonatal factors on parameters of hematopoietic potential in umbilical cord blood. Saudi Med J. 2015; 36:704–712. PMID:
25987113.
Article
27. Kim JP, Lee YH, Lee YA, Kim YD. A comparison of the kinetics of nucleated cells and CD34
+ cells in neonatal peripheral blood and cord blood. Biol Blood Marrow Transplant. 2007; 13:478–485. PMID:
17382254.
28. Liang CC, Liu HL, Chang SD, Chen SH, Lee TH. The protective effect of human umbilical cord blood CD34+ cells and estradiol against focal cerebral ischemia in female ovariectomized rat: cerebral MR imaging and immunohistochemical study. PLoS One. 2016; 11:e0147133. PMID:
26760774.
Article
29. Tsuji M, Taguchi A, Ohshima M, Kasahara Y, Sato Y, Tsuda H, et al. Effects of intravenous administration of umbilical cord blood CD34(+) cells in a mouse model of neonatal stroke. Neuroscience. 2014; 263:148–158. PMID:
24444827.
Article
30. Boltze J, Reich DM, Hau S, Reymann KG, Strassburger M, Lobsien D, et al. Assessment of neuroprotective effects of human umbilical cord blood mononuclear cell subpopulations in vitro and in vivo. Cell Transplant. 2012; 21:723–737. PMID:
21929866.
Article
31. Haase VH. Regulation of erythropoiesis by hypoxia-inducible factors. Blood Rev. 2013; 27:41–53. PMID:
23291219.
Article
32. Elbuken G, Tanriverdi F, Karaca Z, Eser B, Hasdiraz L, Unluhizarci K, et al. Evaluation of peripheral blood CD34
+ cell count in the acute phase of traumatic brain injury and chest trauma. Brain Inj. 2016; 30:179–183. PMID:
26649467.
33. Cotten CM, Murtha AP, Goldberg RN, Grotegut CA, Smith PB, Goldstein RF, et al. Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy. J Pediatr. 2014; 164:973–979.e1. PMID:
24388332.
Article
34. Aly H, Mohsen L, Badrawi N, Gabr H, Ali Z, Akmal D. Viability and neural differentiation of mesenchymal stem cells derived from the umbilical cord following perinatal asphyxia. J Perinatol. 2012; 32:671–676. PMID:
22134676.
Article
35. Baburamani AA, Ek CJ, Walker DW, Castillo-Melendez M. Vulnerability of the developing brain to hypoxic-ischemic damage: contribution of the cerebral vasculature to injury and repair? Front Physiol. 2012; 3:424. PMID:
23162470.
Article
36. Fan J, Cai H, Tan WS. Role of the plasma membrane ROS-generating NADPH oxidase in CD34
+ progenitor cells preservation by hypoxia. J Biotechnol. 2007; 130:455–462. PMID:
17610977.
37. Dong W, Yuwen Z, Xiaohui G. The enhanced ability of peripheral mononuclear cells differentiating into neural cells in term infants with good improvement suffering from severe hypoxic ischemic encephalopathy. Iran J Pediatr. 2014; 24:435–440. PMID:
25755867.
38. McCarthy JM, Capullari T, Thompson Z, Zhu Y, Spellacy WN. Umbilical cord nucleated red blood cell counts: normal values and the effect of labor. J Perinatol. 2006; 26:89–92. PMID:
16407961.
Article